1. Engineering extracellular vesicles with macrophage membrane fusion for ameliorating imiquimod-induced psoriatic skin inflammation
   Zeng Wang et al, 2023, Journal of Dermatological Treatment CrossRef
2. Cyclic AMP Response Element Modulator-α Suppresses PD-1 Expression and Promotes Effector CD4+ T Cells in Psoriasis
   Sigrun R. Hofmann et al, 2021, The Journal of Immunology CrossRef
3. PD-L1 Triggered by Binding eIF3I Contributes to the Amelioration of Diabetes-Associated Wound Healing Defects by Regulating IRS4
   Le Kuai et al, 2022, Journal of Investigative Dermatology CrossRef
4. REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model
   Shangyi Wang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
5. Clinicoprognostic and Histopathological Features of Guttate and Plaque Psoriasis Based on PD-1 Expression
   Chang-Jin Jung et al, 2021, Journal of Clinical Medicine CrossRef
6. Polymorphisms of PDCD1 and COL9A1 Genes in Plaque, Palmoplantar and Arthropathic Psoriasis in Romanian Patients
   Doriana-Sorina Lupea-Chilom et al, 2024, Applied Sciences CrossRef
7. Role of co‑inhibitory molecules in the treatment of psoriasis (Review)
   Yue Yao et al, 2024, Experimental and Therapeutic Medicine CrossRef
8. Camrelizumab-Associated Psoriasis
   Hai-Zhen Hui et al, 2022, American Journal of Therapeutics CrossRef